#Clinical trial

#Clinical trial

Paradromics is one of several companies-which include Neuralink, Synchron, Precision Neuroscience, and Cognixion-working on technology to control computers and other devices using brain waves. Known as brain-computer interfaces, or BCIs, these systems capture brain signals associated with movement intention and translate them into commands. The Paradromics study is slated to begin early next year and include two individuals. After collecting data on the first two participants for a year, the company plans to ask the FDA to expand the study to include more volunteers.

I can just put you on a treatment while I'm waiting to understand exactly what your situation is. I don't need to wait to get information back and classify you as drug sensitive, this or that regimen. There is no need to go through all of that.

A single infusion of an experimental gene-editing drug appears safe and effective for cutting cholesterol, possibly for life, according to a small early study released Saturday. The study, which involved 15 volunteers, found one infusion of a drug that uses the CRISPR gene-editing technique could safely reduce cholesterol, as well as levels of harmful triglycerides, by about half.

The research team, a mixture of people from a biotech company and academic labs, used a commercial injection setup that mixes the injection of the DNA with short pulses of electricity. The electricity disrupts the cell membrane, allowing the plasmid DNA to make it inside cells. Based on animal testing, doing this in muscle cells is enough to turn the muscles into factories producing lots of broadly neutralizing antibodies.

Amid the uncertainty surrounding eligibility for and access to the latest Covid-19 vaccine, a new study has found that a common nasal spray could help prevent infection. This randomized placebo-controlled trial examined the effectiveness of the nasal spray azelastine in preventing Covid-19 infection, as published in the journal JAMA Internal Medicine on September 2. Researchers concluded that the chance of developing Covid-19 was about three times lower in the azelastine group compared with the placebo group.

Treatment with henagliflozin is linked to an increase in the length of telomeres, chromosomal caps that shorten over time.

"Gabrielius did really well on the trial. His wounds healed quicker, and his skin was less red and inflamed. His skin was also less itchy which also reduced him scratching."

Eddie Baker, 83, revealed that participation in the EPIC clinical trial for penile cancer, involving immunotherapy and chemotherapy, may have extended his life by two years.

Participants will either get benfotiamine or a placebo pill, and researchers will follow them for 18 months, taking regular brain scans and blood tests.